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IgA Nephropathy S351.73 m2 and 424 with eGFR < 60 mL/min/1.73 m2. Patients with
eGFR < 60 mL/min/1.73 m2 were more likely to be older and smoker, had
history of episodes of chronic tonsillitis and hypertension, had higher levels
of baseline blood pressure, serum uric acid, cholesterol and proteinuria, and
lower levels of hemoglobin, serum albumin and onset of gross hematuria. For
pathological characteristics, they presented with heavier global and
segmental glomerulosclerosis, crescents, tubular atrophy, interstitial fibrosis
and imflammatory cell infiltrates, arteriolar intimal thickening and hyalini-
zation (Table 1). Multivariate logistic model showed that elderly (OR [95%
CI]: 1.071 [1.048, 1.094]), hypertension (OR [95% CI]: 1.071 [1.048,
1.094]), hyperuricemia (OR [95% CI]: 1.008 [1.006, 1.010]), anemia (OR
[95% CI]: 0.977 [0.965, 0.989]), proteinuria (OR [95% CI]: 1.196 [1.010,
1.416]), global glomerular sclerosis (OR [95% CI]: 1.702 [1.499, 1.934]) and
crescents (OR [95% CI]: 1.562 [1.208, 2.020]) were associated with an
increased risk of deterioration of kidney function in IgAN patients (Table 2).
Conclusion:Early screeningof theclinicopathologicalpredictorsplays an impor-
tant role in protection of deterioration of kidney function in IgAN patients.http://dx.doi.org/10.1016/j.hkjn.2015.08.099
0134
Clinical Outcomes of IgA Nephropathy Patients with Different
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Objective: We aimed to investigate the clinicopathological characteristics
and outcomes of IgAN patients with different proportions of crescents.
Methods: Biopsyeproven primary IgAN patients with histological crescents
formation were enrolled in this retrospective cohort study, defined as a com-
posite of doubling of baseline serum creatinine and/or ESRD and/or death.
Results: 538 out of 721 crescent-featured IgAN patients were followed up and
included in the analysis. The median crescent proportion was 8.0% (IQR: 4.5%-
14.3%).We further 25%.Alongwithgrowingcrescentproportionwere reducing
eGFR, decreasing level of hemoglobin and increasing amount of urine protein
excretion. The composite endpoint-free survival rates for the above four sub-
groups were 94.5%, 82.9%, 83.9%, 67.4% at 5 years, and at 10 years (log rank
test c2Z 13.7, pZ 0.003). Multivariate Cox regression analyses adjusting for
eGFR,hypertension,proteinuria,andOxford-MESTdemonstratedthepredictiveFigure 1. Clinical outcomes of IgAN patients with different proportions of
crescents.significance of increasing crescent proportion with adverse outcomes [every in-
crease by 5% (log-transformed): HRZ 1.51, 95% CI 1.08-2.11, pZ 0.015].
Conclusion: Increasing crescent proportion was evidenced to be one of inde-
pendent predictors for adverse outcomes adjusting for both clinical param-
eters and Oxford-MEST in IgAN. Consequently, the formation of crescents in
small proportion should be attached sufficient attention in clinical practice.http://dx.doi.org/10.1016/j.hkjn.2015.08.100
0146
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Objective: This study aimed to investigate the clinicopathological features
and prognosis of IgA nephropathy (IgAN) patients with endocapillary
proliferation.
Methods: This is a single center, retrospective, cohort study. Patients were
assigned to two groups according to whether they had endocapillary prolig-
eration (E1 group) or not (E0 group). The clinicopathological features and
outcome during follow-up were collected and analyzed. The primary
outcome was end stage renal disease (ESRD) (eGFR < 15 ml/min/1.73 m2,
dialysis, or renal transplantation) or doubling of baseline serum creatinine.
The impact of endocapillary proliferation on renal outcome was evaluated
by cox proportional hazard model.
Results: A total of 1570 patients were screened. After excluding 388 patients
without endocapillary proliferation data, 1182 patients were enrolled and 431
(36.5%) were assigned to E1 group. Compared to E0 group, patients in E1
group had a smaller proportion of smokers, lower level of hemoglobin and al-
bumin, while they had a higher level of uric acid and 24-hour urinary protein
excretion. In addition, E1 group presented with a larger proportion of cres-
cent, arteriolar wall thickness, capillary loops necrosis and segmental scle-
rosis, and more severe tubular atrophy/interstitial fibrosis. A total of 825
patients were included in the subsequent study with a median follow-up
time of 47.5 (34.4, 58.8) months. The Kaplan-Meier curve showed that renal
survival rates calculated from the combined events at 3, 5, and 7 years were
91%, 83%, 83% in E1 group. Endocapillary proliferation was not an indepen-
dent risk factor for renal outcome (OR Z 1.47, 95% CI 0.89e2.43,
PZ 0.136). Younger age, glomerulosclerosis, segmental sclerosis, larger cres-
cent proportion and interstitial inflammatory infiltration were independent
risk factors for renal outcome in patients with endocapillary proliferation.
Conclusion: IgAN patients with endocapillary proliferation presented with
worse clinicopathological features. No significant association was found be-
tween endocapillary proliferation and renal outcome.http://dx.doi.org/10.1016/j.hkjn.2015.08.101
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Objective: This study aimed to investigate the incidence of abnormal circa-
dian blood pressure rhythm in patients with IgA nephropathy (IgAN) and
analyze its associations with clinical pathological characteristics and
possible related risk factors.
Methods: Patients who were biopsy-proven primary IgAN from June 2013 and
December 2014 in our hospital were recruited and underwent 24-hour ambu-
latory blood pressure monitoring (ABPM) and ultrasonographic assessment. 24
S36 IgA Nephropathyhours, daytime and nighttime systolic and diastolic BP variations were calcu-
lated. The patients were divided into four groups based on different circa-
dian BP rhythm: dippers, non-dippers, reversed dippers, and extreme
dippers. Demographic and clinicopathologic data were collected and
analyzed. Logistic regression models were used to analyze the associated fac-
tors for abnormal BP rhythms among the patients with IgAN.
Results: A total of 375 IgAN patients were recruited and the mean age was
(36.5 11.7) years with 51.7% (194/375) men. The prevalence of abnormal
circadian BP was high to 84% (315/375), with 82.4% in normotensive and
86.1% in hypertensive patients (P > 0.05). The non-dipper rhythm was the
most common abnormal pattern (63.8%, 239/375), and then was reversed
dipper (27.3%, 86/315), extreme dipper (8.9%, 28/315). Compared to the pa-
tients with normal BP rhythm, the patients with abnormal BP rhythms had
higher left ventricular mass index, higher serum creatinine and uric acid but
lower eGFR, higher proportion of arteriole wall thickening and small vascular
hyalinosis, which was the most distinguishing in those with reversed dipper
BP. Multivariate logistic regression analysis revealed that the eGFR (OR: 0.64,
95% CI: 0.45e0.93, PZ 0.037), serum uric acid (OR: 1.60, 95% CI: 1.01e2.54,
P Z 0.014) and small vascular hyalinosis (OR: 2.17, 95% CI: 1.14e4.11,
PZ 0.044)were independently associatedwith abnormal BP circadian rhythm.
Conclusion: Abnormal circadian BP rhythm was common in IgAN patients inde-
pendent of hypertension. The associated factors for abnormal BP rhythmamong
IgAN patients were the eGFR, serum uric acid, and small vascular hyalinosis.http://dx.doi.org/10.1016/j.hkjn.2015.08.102
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Background: IgG4-RD is known to involve the kidneys. We report two pa-
tients with IgG4-RD and concomitant renal pathology.
Cases: A 61-year-old male presented with microscopic haematuria, renal
impairment [serum creatinine (SCr) 160 umol/mL], proteinuria and anaemia.
Renal biopsy showed features of IgAN. Positron emission tomography scan
revealed generalised lymphadenopathy and splenomegaly. Five years later,
his renal function deteriorated (SCr 326 umol/mL). Cervical lymph node bi-
opsy showed IgG4-related lymphadenopathy. Repeat renal biopsy showed
interstitial nephritis with lymphoplasmacytic infiltration (Figure 1), with
30e40% of IgG-positive plasma cells stained positive for IgG4 (Figure 2),
and features of IgAN. Serum IgG4 level was raised to 1500 mg/dL (range
0e291 mg/dL). He was treated with prednisolone, renal function returned
to baseline in 2 months and serum IgG4 levels also decreased. This patient
remained steroid dependent for the next 5 years. The second patient was
a 62-year-old male who presented with lung mass and nephrotic syndrome.
Computed tomography scan of the thorax showed right lung mass with
lymphadenopathies. Submandibular mass biopsy showed IgG4-related
chronic sclerosing sialadenitis. Renal biopsy showed IgAN with minimal
change-like lesion. There was no tubulointerstitial nephritis and staining
for IgG4 was negative. His serum IgG4 level was elevated. His nephrotic syn-
drome, lymphadenopathy and lung mass all responded to prednisolone ther-
apy. However, nephrotic syndrome relapsed 1 month after stopping steroid
and was steroid dependent.
Conclusion: We reported two patients with IgG4-RD and renal pathology of
IgAN. One patient had IgG4-related kidney disease (IgG4-RKD) confirmed onrenal biopsy. Whilst classical renal histopathology of IgG4-RKD is tubulointer-
stitial nephritis, the two cases showed histological features of IgAN. Both pa-
tients are steroid dependent. IgAN is a common glomerulonephritis in the
oriental population. The presence of both IgAN and IgG4-RD in these patients
could be coincidental. Further studies are needed to assess whether there is
an association between the two conditions.http://dx.doi.org/10.1016/j.hkjn.2015.08.103
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Objective: This study aimed to assess the long-term renal survival rate and
related associated factors of renal progession in IgAN with different sexes.
Methods: This is a single center, retrospective, cohort study. All enrolled
patients were divided into two groups by sex. Clinical and pathological
information were collected and analyzed. The clinical outcomes and
associated factors were evaluated by Kaplan-Meier Estimation and Cox
regression.
Results: A total of 988 eligible IgAN patients (M/F 1:1.4) were enrolled.
Compared to females, males with IgAN exhibited worse renal function,
greater proteinuria, and more frequent occurrence of hypertension,
hypertriglyceridemia and hyperuricemia. Besides, males had more severe
segmental sclerosis and tubular-atrophy/interstitial fibrosis. For females,
hematuria was more frequent. The 3-, 5- and 7-year cumulative renal
survival rates were 92.9%, 84.3%, 73.1% in males; 95.6%, 89.4%, 75.8%
in females, respectively. But no significant difference was noted in the
cumulative renal survival rate between sexes (log-rank test P Z 0.090).
Multivariate Cox regression analyses revealed that sex difference was
not risk factor for renal outcomes after matching baseline eGFR and
SUA. In males, lower eGFR (HR: 0.67, P < 0.001) and degree of glomerular
sclerosis (HR: 1.02, P Z 0.038) were risk factors for renal outcome.
Whereas in females, prognosis factors of renal survival included not
only eGFR (HR: 0.81, P < 0.001) and glomerular sclerosis (HR: 1.03,
P Z 0.001) but also proteinuria (HR: 1.37, P Z 0.002), age (HR: 0.61,
P Z 0.008) and segmental sclerosis (HR: 1.03, P Z 0.035).
Conclusion: This study found that males with IgAN presented worse clinico-
pathological changes than females, but no significant difference was seen in
long-term renal survival between the sexes. Lower eGFR and glomerular
sclerosis were risk factors for renal outcome in both sexes. Higher protein-
uria, younger age and degree of segmental sclerosis were associated with
a worse renal outcome in women but not in men.http://dx.doi.org/10.1016/j.hkjn.2015.08.104
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Objective: To investigate the treatment response and long-term effects of
combination therapy with mycophenolate mofetil (MMF) and glucocorticoids
compared to glucocorticoids alone in IgA nephropathy (IgAN).
Methods: Two hundred and seven IgAN patients with persistent proteinuria (
1 g/day), estimated glomerular filtration (eGFR) > 30 ml/min/1.73 m2 were
enrolled. 126 patients received methyl-prednisolone only (MP group). 81 pa-
tients received MMF and methyl-prednisolone (combination group). The me-
dian follow-up time was 41 months (12e101). The primary endpoint was
defined as double of serum creatinine or progress to end stage renal disease
(ESRD). A decrease in the baseline eGFR of 25% was defined as renal survival.
Results: The urinary proteinuria declined significantly from 2.83 2.48 g/
day to 0.69 0.73 g/day (P < 0.05) in combination group and from
2.88 2.6 g/day to 0.82 1.16 g/day in the MP group (P < 0.05). The
